Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.

Clin Lung Cancer

Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom. Electronic address:

Published: March 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2023.12.001DOI Listing

Publication Analysis

Top Keywords

report updated
4
updated efficacy
4
efficacy safety
4
safety data
4
data integrated
4
integrated analysis
4
analysis entrectinib
4
entrectinib locally
4
locally advanced/metastatic
4
advanced/metastatic ros1
4

Similar Publications

Background: Breast cancer screening in Aotearoa New Zealand (NZ) still has persistent inequitable coverage by ethnicity, especially for Indigenous Māori women. This project aimed to undertake systematic data linkage to identify and invite eligible Māori women to participate in breast screening.

Methods: This is a cross-sectional observational study conducted in Northern New Zealand between 1/01/2020 and 30/06/2021.

View Article and Find Full Text PDF

Advances in gynaecologic oncology research lead to continuous updates in clinical guidelines. However, undergraduate medical education often lacks in-depth coverage of recent developments, limiting students' preparedness for evidence-based management of gynaecological cancers. This study aimed to bridge the educational gap by integrating case-based analyses of practice-changing studies into the undergraduate obstetrics and gynaecology course.

View Article and Find Full Text PDF

Background: Trastuzumab deruxtecan (T-DXd) has shown promising activity in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) and central nervous system (CNS) involvement. In this updated meta-analysis, we explore the effectiveness of T-DXd in a large subset of patients with HER2-positive BC and CNS disease.

Methods: A systematic search was made on September 16th, 2024, for studies investigating T-DXd in the scenario of HER2-positive BC and brain metastases (BMs) and/or leptomeningeal disease (LMD).

View Article and Find Full Text PDF

Cost efficiency of commercial banks in Ethiopia: Does financial technology matter?

PLoS One

January 2025

Department of Public Financial Management and Accounting, Ethiopian Civil Service University, Addis Ababa, Ethiopia.

This study aims to assess the effects of financial technology on the cost efficiency of commercial banks in Ethiopia. Secondary panel data were collected from the audited annual reports of seventeen commercial banks for twelve fiscal years between 2011 and 2022. The cost efficiency of banks was investigated via a stochastic frontier approach.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!